Cargando…
Cellular based treatment modalities for unresectable hepatocellular carcinoma
Hepatocellular carcinoma (HCC) is the most common primary malignancy of the liver and is unfortunately associated with an overall poor prognosis and high mortality. Early and intermediate stages of HCC allow for treatment with surgical resection, ablation and even liver transplantation, however dise...
Autores principales: | Damiris, Konstantinos, Abbad, Hamza, Pyrsopoulos, Nikolaos |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8173328/ https://www.ncbi.nlm.nih.gov/pubmed/34131562 http://dx.doi.org/10.5306/wjco.v12.i5.290 |
Ejemplares similares
-
Efficacy and safety of anti-hepatic fibrosis drugs
por: Damiris, Konstantinos, et al.
Publicado: (2020) -
Hepatitis E in immunocompromised individuals
por: Damiris, Konstantinos, et al.
Publicado: (2022) -
Profile of tivantinib and its potential in the treatment of hepatocellular carcinoma: the evidence to date
por: Pievsky, Daniel, et al.
Publicado: (2016) -
Sorafenib for the treatment of unresectable hepatocellular carcinoma
por: Furuse, Junji
Publicado: (2008) -
Management and Treatment of Hepatocellular Carcinoma with Immunotherapy: A Review of Current and Future Options
por: Ghavimi, Shima, et al.
Publicado: (2020)